- Home
- PFLT vs CADL Comparison
PFLT vs CADL Comparison
Compare PFLT & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PFLT
- CADL
- Stock Information
- Founded
- PFLT 2010
- CADL 1999
- Country
- PFLT United States
- CADL United States
- Employees
- PFLT N/A
- CADL N/A
- Industry
- PFLT Finance: Consumer Services
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- PFLT Finance
- CADL Health Care
- Exchange
- PFLT Nasdaq
- CADL Nasdaq
- Market Cap
- PFLT 1.0B
- CADL 252.0M
- IPO Year
- PFLT N/A
- CADL 2021
- Fundamental
- Price
- PFLT $10.57
- CADL $5.50
- Analyst Decision
- PFLT Buy
- CADL Strong Buy
- Analyst Count
- PFLT 6
- CADL 5
- Target Price
- PFLT $11.17
- CADL $21.40
- AVG Volume (30 Days)
- PFLT 782.6K
- CADL 866.1K
- Earning Date
- PFLT 08-11-2025
- CADL 08-12-2025
- Dividend Yield
- PFLT 11.65%
- CADL N/A
- EPS Growth
- PFLT N/A
- CADL N/A
- EPS
- PFLT 0.86
- CADL N/A
- Revenue
- PFLT $232,975,000.00
- CADL N/A
- Revenue This Year
- PFLT $45.52
- CADL N/A
- Revenue Next Year
- PFLT $8.87
- CADL N/A
- P/E Ratio
- PFLT $12.25
- CADL N/A
- Revenue Growth
- PFLT 49.56
- CADL N/A
- 52 Week Low
- PFLT $8.82
- CADL $3.79
- 52 Week High
- PFLT $12.02
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- PFLT 61.46
- CADL 57.20
- Support Level
- PFLT $10.44
- CADL $4.86
- Resistance Level
- PFLT $10.59
- CADL $5.12
- Average True Range (ATR)
- PFLT 0.14
- CADL 0.28
- MACD
- PFLT 0.03
- CADL 0.06
- Stochastic Oscillator
- PFLT 90.83
- CADL 88.26
About PFLT PennantPark Floating Rate Capital Ltd.
PennantPark Floating Rate Capital Ltd is a closed-end, externally managed, non-diversified investment company. Its investment objectives are to generate current income and capital appreciation by investing in Floating Rate Loans and other investments made to U.S. middle-market companies. The company believes that Floating Rate Loans to U.S. middle-market companies offer attractive risk-reward to investors due to the limited amount of capital available for such companies and the potential for rising interest rates. The company generate revenue in the form of interest income on the debt securities and dividends.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.